There's the pro forma number and then the non-proforma number....bit of a wishy washy period as there has been acquisitions. Generally speaking though I think the continue to deliver on their guidance which is a positive, however losses are growing but perhaps as a result of the costs of acquistitions and marketing - so it's to be expected.
- Forums
- ASX - By Stock
- CAT
- Ann: CAT reports solid H1 performance, reaffirms FY18 guidance
CAT
catapult group international ltd
Add to My Watchlist
0.00%
!
$5.80

Ann: CAT reports solid H1 performance, reaffirms FY18 guidance, page-8
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$5.80 |
Change
0.000(0.00%) |
Mkt cap ! $1.645B |
Open | High | Low | Value | Volume |
$5.88 | $5.88 | $5.73 | $4.453M | 768.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 450 | $5.75 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$5.80 | 2500 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 200 | 5.740 |
2 | 2240 | 5.700 |
1 | 3 | 5.670 |
1 | 495 | 5.650 |
1 | 15078 | 5.630 |
Price($) | Vol. | No. |
---|---|---|
5.800 | 2500 | 1 |
5.820 | 6024 | 1 |
5.900 | 550 | 1 |
5.950 | 9110 | 4 |
6.000 | 26527 | 10 |
Last trade - 16.17pm 04/07/2025 (20 minute delay) ? |
Featured News
CAT (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online